nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—seminal vesicle—testicular cancer	0.0318	0.168	CbGeAlD
Vigabatrin—GABBR1—female gonad—testicular cancer	0.0187	0.0988	CbGeAlD
Vigabatrin—SLC36A1—gonad—testicular cancer	0.018	0.0955	CbGeAlD
Vigabatrin—ABAT—gonad—testicular cancer	0.0179	0.0949	CbGeAlD
Vigabatrin—GABBR1—testis—testicular cancer	0.0165	0.0876	CbGeAlD
Vigabatrin—SLC36A1—female gonad—testicular cancer	0.0147	0.0776	CbGeAlD
Vigabatrin—ABAT—female gonad—testicular cancer	0.0146	0.0771	CbGeAlD
Vigabatrin—SLC36A1—testis—testicular cancer	0.013	0.0688	CbGeAlD
Vigabatrin—ABAT—testis—testicular cancer	0.0129	0.0684	CbGeAlD
Vigabatrin—GABBR1—lymph node—testicular cancer	0.012	0.0635	CbGeAlD
Vigabatrin—SLC36A1—lymph node—testicular cancer	0.00942	0.0499	CbGeAlD
Vigabatrin—ABAT—lymph node—testicular cancer	0.00936	0.0496	CbGeAlD
Vigabatrin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000813	0.001	CcSEcCtD
Vigabatrin—Decreased appetite—Cisplatin—testicular cancer	0.000812	0.001	CcSEcCtD
Vigabatrin—Bronchitis—Epirubicin—testicular cancer	0.000811	0.001	CcSEcCtD
Vigabatrin—Diarrhoea—Dactinomycin—testicular cancer	0.000809	0.000997	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—testicular cancer	0.000808	0.000996	CcSEcCtD
Vigabatrin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000807	0.000995	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000806	0.000994	CcSEcCtD
Vigabatrin—Vomiting—Bleomycin—testicular cancer	0.000806	0.000993	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—testicular cancer	0.000803	0.00099	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—testicular cancer	0.000803	0.00099	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—testicular cancer	0.000803	0.00099	CcSEcCtD
Vigabatrin—Depression—Methotrexate—testicular cancer	0.000801	0.000988	CcSEcCtD
Vigabatrin—Rash—Bleomycin—testicular cancer	0.000799	0.000985	CcSEcCtD
Vigabatrin—Pain—Cisplatin—testicular cancer	0.000799	0.000984	CcSEcCtD
Vigabatrin—Dermatitis—Bleomycin—testicular cancer	0.000798	0.000984	CcSEcCtD
Vigabatrin—Hypersensitivity—Ifosfamide—testicular cancer	0.000798	0.000984	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000797	0.000982	CcSEcCtD
Vigabatrin—Abdominal distension—Doxorubicin—testicular cancer	0.000785	0.000968	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000784	0.000966	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—testicular cancer	0.000781	0.000963	CcSEcCtD
Vigabatrin—Influenza—Doxorubicin—testicular cancer	0.00078	0.000962	CcSEcCtD
Vigabatrin—Asthenia—Ifosfamide—testicular cancer	0.000777	0.000958	CcSEcCtD
Vigabatrin—Feeling abnormal—Cisplatin—testicular cancer	0.000769	0.000949	CcSEcCtD
Vigabatrin—Paraesthesia—Etoposide—testicular cancer	0.000768	0.000947	CcSEcCtD
Vigabatrin—Weight increased—Epirubicin—testicular cancer	0.000767	0.000946	CcSEcCtD
Vigabatrin—Pruritus—Ifosfamide—testicular cancer	0.000766	0.000945	CcSEcCtD
Vigabatrin—Somnolence—Etoposide—testicular cancer	0.000761	0.000938	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—testicular cancer	0.00076	0.000937	CcSEcCtD
Vigabatrin—Pneumonia—Epirubicin—testicular cancer	0.000756	0.000932	CcSEcCtD
Vigabatrin—Nausea—Bleomycin—testicular cancer	0.000753	0.000928	CcSEcCtD
Vigabatrin—Infestation NOS—Epirubicin—testicular cancer	0.000752	0.000927	CcSEcCtD
Vigabatrin—Drowsiness—Epirubicin—testicular cancer	0.000752	0.000927	CcSEcCtD
Vigabatrin—Infestation—Epirubicin—testicular cancer	0.000752	0.000927	CcSEcCtD
Vigabatrin—Vomiting—Dactinomycin—testicular cancer	0.000752	0.000926	CcSEcCtD
Vigabatrin—Bronchitis—Doxorubicin—testicular cancer	0.00075	0.000925	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000745	0.000919	CcSEcCtD
Vigabatrin—Rash—Dactinomycin—testicular cancer	0.000745	0.000919	CcSEcCtD
Vigabatrin—Decreased appetite—Etoposide—testicular cancer	0.000744	0.000917	CcSEcCtD
Vigabatrin—Diarrhoea—Ifosfamide—testicular cancer	0.000741	0.000914	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000739	0.00091	CcSEcCtD
Vigabatrin—Body temperature increased—Cisplatin—testicular cancer	0.000738	0.00091	CcSEcCtD
Vigabatrin—Fatigue—Etoposide—testicular cancer	0.000738	0.000909	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000737	0.000909	CcSEcCtD
Vigabatrin—Constipation—Etoposide—testicular cancer	0.000732	0.000902	CcSEcCtD
Vigabatrin—Pain—Etoposide—testicular cancer	0.000732	0.000902	CcSEcCtD
Vigabatrin—Urinary tract infection—Epirubicin—testicular cancer	0.000731	0.000901	CcSEcCtD
Vigabatrin—Conjunctivitis—Epirubicin—testicular cancer	0.000731	0.000901	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000725	0.000894	CcSEcCtD
Vigabatrin—Dizziness—Ifosfamide—testicular cancer	0.000716	0.000883	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000711	0.000877	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—testicular cancer	0.00071	0.000875	CcSEcCtD
Vigabatrin—Sinusitis—Epirubicin—testicular cancer	0.000705	0.00087	CcSEcCtD
Vigabatrin—Feeling abnormal—Etoposide—testicular cancer	0.000705	0.000869	CcSEcCtD
Vigabatrin—Nausea—Dactinomycin—testicular cancer	0.000702	0.000865	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—testicular cancer	0.0007	0.000863	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Etoposide—testicular cancer	0.0007	0.000862	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—testicular cancer	0.000696	0.000858	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—testicular cancer	0.000696	0.000858	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—testicular cancer	0.000696	0.000858	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—testicular cancer	0.000695	0.000857	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00069	0.00085	CcSEcCtD
Vigabatrin—Vomiting—Ifosfamide—testicular cancer	0.000689	0.000849	CcSEcCtD
Vigabatrin—Hypersensitivity—Cisplatin—testicular cancer	0.000688	0.000848	CcSEcCtD
Vigabatrin—Rash—Ifosfamide—testicular cancer	0.000683	0.000842	CcSEcCtD
Vigabatrin—Dermatitis—Ifosfamide—testicular cancer	0.000682	0.000841	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—testicular cancer	0.000682	0.000841	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000682	0.000841	CcSEcCtD
Vigabatrin—Urticaria—Etoposide—testicular cancer	0.00068	0.000838	CcSEcCtD
Vigabatrin—Abdominal pain—Etoposide—testicular cancer	0.000676	0.000834	CcSEcCtD
Vigabatrin—Body temperature increased—Etoposide—testicular cancer	0.000676	0.000834	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—testicular cancer	0.000676	0.000834	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—testicular cancer	0.000676	0.000834	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—testicular cancer	0.000674	0.000831	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—testicular cancer	0.000672	0.000829	CcSEcCtD
Vigabatrin—Hypoaesthesia—Epirubicin—testicular cancer	0.000672	0.000828	CcSEcCtD
Vigabatrin—Asthenia—Cisplatin—testicular cancer	0.00067	0.000826	CcSEcCtD
Vigabatrin—Oedema peripheral—Epirubicin—testicular cancer	0.000665	0.00082	CcSEcCtD
Vigabatrin—Connective tissue disorder—Epirubicin—testicular cancer	0.000663	0.000818	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000658	0.000811	CcSEcCtD
Vigabatrin—Sinusitis—Doxorubicin—testicular cancer	0.000653	0.000805	CcSEcCtD
Vigabatrin—Visual impairment—Epirubicin—testicular cancer	0.00065	0.000802	CcSEcCtD
Vigabatrin—Nausea—Ifosfamide—testicular cancer	0.000643	0.000793	CcSEcCtD
Vigabatrin—Diarrhoea—Cisplatin—testicular cancer	0.000639	0.000788	CcSEcCtD
Vigabatrin—Erythema multiforme—Epirubicin—testicular cancer	0.000638	0.000787	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—testicular cancer	0.000632	0.000779	CcSEcCtD
Vigabatrin—Eye disorder—Epirubicin—testicular cancer	0.000631	0.000778	CcSEcCtD
Vigabatrin—Hypersensitivity—Etoposide—testicular cancer	0.00063	0.000777	CcSEcCtD
Vigabatrin—Tinnitus—Epirubicin—testicular cancer	0.000629	0.000776	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—testicular cancer	0.000628	0.000774	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000621	0.000766	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—testicular cancer	0.000615	0.000758	CcSEcCtD
Vigabatrin—Asthenia—Etoposide—testicular cancer	0.000614	0.000757	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000614	0.000757	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—testicular cancer	0.000607	0.000749	CcSEcCtD
Vigabatrin—Pruritus—Etoposide—testicular cancer	0.000605	0.000746	CcSEcCtD
Vigabatrin—Visual impairment—Doxorubicin—testicular cancer	0.000602	0.000742	CcSEcCtD
Vigabatrin—Vomiting—Cisplatin—testicular cancer	0.000594	0.000732	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—testicular cancer	0.000592	0.000729	CcSEcCtD
Vigabatrin—Mental disorder—Epirubicin—testicular cancer	0.000591	0.000729	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—testicular cancer	0.00059	0.000728	CcSEcCtD
Vigabatrin—Rash—Cisplatin—testicular cancer	0.000589	0.000726	CcSEcCtD
Vigabatrin—Dermatitis—Cisplatin—testicular cancer	0.000588	0.000725	CcSEcCtD
Vigabatrin—Malnutrition—Epirubicin—testicular cancer	0.000588	0.000724	CcSEcCtD
Vigabatrin—Diarrhoea—Etoposide—testicular cancer	0.000585	0.000722	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—testicular cancer	0.000584	0.000719	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—testicular cancer	0.000583	0.000718	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—testicular cancer	0.000582	0.000718	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—testicular cancer	0.00058	0.000715	CcSEcCtD
Vigabatrin—Tension—Epirubicin—testicular cancer	0.000577	0.000711	CcSEcCtD
Vigabatrin—Nervousness—Epirubicin—testicular cancer	0.000571	0.000703	CcSEcCtD
Vigabatrin—Back pain—Epirubicin—testicular cancer	0.000568	0.000701	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—testicular cancer	0.000566	0.000698	CcSEcCtD
Vigabatrin—Dizziness—Etoposide—testicular cancer	0.000566	0.000697	CcSEcCtD
Vigabatrin—Muscle spasms—Epirubicin—testicular cancer	0.000565	0.000696	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—testicular cancer	0.000564	0.000695	CcSEcCtD
Vigabatrin—Nausea—Cisplatin—testicular cancer	0.000555	0.000684	CcSEcCtD
Vigabatrin—Vision blurred—Epirubicin—testicular cancer	0.000554	0.000683	CcSEcCtD
Vigabatrin—Cough—Methotrexate—testicular cancer	0.000548	0.000675	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—testicular cancer	0.000547	0.000674	CcSEcCtD
Vigabatrin—Ill-defined disorder—Epirubicin—testicular cancer	0.000545	0.000672	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—testicular cancer	0.000544	0.000671	CcSEcCtD
Vigabatrin—Vomiting—Etoposide—testicular cancer	0.000544	0.000671	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—testicular cancer	0.000544	0.00067	CcSEcCtD
Vigabatrin—Anaemia—Epirubicin—testicular cancer	0.000543	0.000669	CcSEcCtD
Vigabatrin—Agitation—Epirubicin—testicular cancer	0.00054	0.000666	CcSEcCtD
Vigabatrin—Rash—Etoposide—testicular cancer	0.000539	0.000665	CcSEcCtD
Vigabatrin—Dermatitis—Etoposide—testicular cancer	0.000539	0.000664	CcSEcCtD
Vigabatrin—Headache—Etoposide—testicular cancer	0.000536	0.000661	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—testicular cancer	0.000535	0.000659	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—testicular cancer	0.000535	0.000659	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—testicular cancer	0.000535	0.000659	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—testicular cancer	0.000533	0.000658	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000531	0.000654	CcSEcCtD
Vigabatrin—Malaise—Epirubicin—testicular cancer	0.00053	0.000653	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—testicular cancer	0.000528	0.000651	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—testicular cancer	0.000528	0.000651	CcSEcCtD
Vigabatrin—Vertigo—Epirubicin—testicular cancer	0.000528	0.000651	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—testicular cancer	0.000526	0.000648	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—testicular cancer	0.000523	0.000644	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—testicular cancer	0.000517	0.000637	CcSEcCtD
Vigabatrin—Cough—Epirubicin—testicular cancer	0.000513	0.000632	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—testicular cancer	0.000512	0.000632	CcSEcCtD
Vigabatrin—Convulsion—Epirubicin—testicular cancer	0.000509	0.000628	CcSEcCtD
Vigabatrin—Infection—Methotrexate—testicular cancer	0.000509	0.000628	CcSEcCtD
Vigabatrin—Nausea—Etoposide—testicular cancer	0.000508	0.000626	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000504	0.000622	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—testicular cancer	0.000503	0.000619	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—testicular cancer	0.000502	0.000619	CcSEcCtD
Vigabatrin—Chest pain—Epirubicin—testicular cancer	0.0005	0.000617	CcSEcCtD
Vigabatrin—Arthralgia—Epirubicin—testicular cancer	0.0005	0.000617	CcSEcCtD
Vigabatrin—Myalgia—Epirubicin—testicular cancer	0.0005	0.000617	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—testicular cancer	0.0005	0.000616	CcSEcCtD
Vigabatrin—Anxiety—Epirubicin—testicular cancer	0.000498	0.000615	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—testicular cancer	0.000498	0.000614	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000497	0.000612	CcSEcCtD
Vigabatrin—Discomfort—Epirubicin—testicular cancer	0.000494	0.000609	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—testicular cancer	0.00049	0.000604	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—testicular cancer	0.000488	0.000602	CcSEcCtD
Vigabatrin—Confusional state—Epirubicin—testicular cancer	0.000484	0.000596	CcSEcCtD
Vigabatrin—Oedema—Epirubicin—testicular cancer	0.00048	0.000591	CcSEcCtD
Vigabatrin—Infection—Epirubicin—testicular cancer	0.000476	0.000587	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—testicular cancer	0.000474	0.000585	CcSEcCtD
Vigabatrin—Convulsion—Doxorubicin—testicular cancer	0.000471	0.000581	CcSEcCtD
Vigabatrin—Nervous system disorder—Epirubicin—testicular cancer	0.00047	0.00058	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000467	0.000576	CcSEcCtD
Vigabatrin—Skin disorder—Epirubicin—testicular cancer	0.000466	0.000574	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—testicular cancer	0.000463	0.000571	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—testicular cancer	0.000463	0.000571	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—testicular cancer	0.000463	0.000571	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—testicular cancer	0.000463	0.000571	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—testicular cancer	0.000461	0.000569	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—testicular cancer	0.00046	0.000567	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00046	0.000567	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—testicular cancer	0.000457	0.000564	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—testicular cancer	0.000456	0.000562	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—testicular cancer	0.000451	0.000556	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—testicular cancer	0.000447	0.000552	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—testicular cancer	0.000445	0.000549	CcSEcCtD
Vigabatrin—Oedema—Doxorubicin—testicular cancer	0.000444	0.000547	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000442	0.000545	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—testicular cancer	0.000442	0.000545	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—testicular cancer	0.000441	0.000543	CcSEcCtD
Vigabatrin—Pain—Methotrexate—testicular cancer	0.000438	0.00054	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000437	0.000539	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—testicular cancer	0.000435	0.000536	CcSEcCtD
Vigabatrin—Insomnia—Epirubicin—testicular cancer	0.000434	0.000535	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—testicular cancer	0.000431	0.000531	CcSEcCtD
Vigabatrin—Paraesthesia—Epirubicin—testicular cancer	0.000431	0.000531	CcSEcCtD
Vigabatrin—Somnolence—Epirubicin—testicular cancer	0.000426	0.000526	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—testicular cancer	0.000422	0.000521	CcSEcCtD
Vigabatrin—Dyspepsia—Epirubicin—testicular cancer	0.000422	0.00052	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000419	0.000517	CcSEcCtD
Vigabatrin—Decreased appetite—Epirubicin—testicular cancer	0.000417	0.000514	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000414	0.00051	CcSEcCtD
Vigabatrin—Fatigue—Epirubicin—testicular cancer	0.000413	0.00051	CcSEcCtD
Vigabatrin—Constipation—Epirubicin—testicular cancer	0.00041	0.000506	CcSEcCtD
Vigabatrin—Pain—Epirubicin—testicular cancer	0.00041	0.000506	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—testicular cancer	0.000407	0.000502	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—testicular cancer	0.000405	0.000499	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—testicular cancer	0.000405	0.000499	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000404	0.000498	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—testicular cancer	0.000401	0.000495	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—testicular cancer	0.000398	0.000491	CcSEcCtD
Vigabatrin—Feeling abnormal—Epirubicin—testicular cancer	0.000395	0.000487	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—testicular cancer	0.000394	0.000486	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000392	0.000483	CcSEcCtD
Vigabatrin—Dyspepsia—Doxorubicin—testicular cancer	0.000391	0.000481	CcSEcCtD
Vigabatrin—Decreased appetite—Doxorubicin—testicular cancer	0.000386	0.000475	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000383	0.000472	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—testicular cancer	0.000383	0.000472	CcSEcCtD
Vigabatrin—Urticaria—Epirubicin—testicular cancer	0.000381	0.00047	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—testicular cancer	0.000379	0.000468	CcSEcCtD
Vigabatrin—Pain—Doxorubicin—testicular cancer	0.000379	0.000468	CcSEcCtD
Vigabatrin—Abdominal pain—Epirubicin—testicular cancer	0.000379	0.000467	CcSEcCtD
Vigabatrin—Body temperature increased—Epirubicin—testicular cancer	0.000379	0.000467	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—testicular cancer	0.000378	0.000465	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—testicular cancer	0.000368	0.000453	CcSEcCtD
Vigabatrin—Feeling abnormal—Doxorubicin—testicular cancer	0.000366	0.000451	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000363	0.000447	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—testicular cancer	0.000363	0.000447	CcSEcCtD
Vigabatrin—Hypersensitivity—Epirubicin—testicular cancer	0.000353	0.000436	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—testicular cancer	0.000352	0.000435	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—testicular cancer	0.000351	0.000432	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—testicular cancer	0.000351	0.000432	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—testicular cancer	0.000351	0.000432	CcSEcCtD
Vigabatrin—Asthenia—Epirubicin—testicular cancer	0.000344	0.000424	CcSEcCtD
Vigabatrin—Pruritus—Epirubicin—testicular cancer	0.000339	0.000418	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—testicular cancer	0.000339	0.000418	CcSEcCtD
Vigabatrin—Diarrhoea—Epirubicin—testicular cancer	0.000328	0.000404	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—testicular cancer	0.000327	0.000403	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—testicular cancer	0.000326	0.000402	CcSEcCtD
Vigabatrin—Rash—Methotrexate—testicular cancer	0.000323	0.000398	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—testicular cancer	0.000323	0.000398	CcSEcCtD
Vigabatrin—Headache—Methotrexate—testicular cancer	0.000321	0.000396	CcSEcCtD
Vigabatrin—Asthenia—Doxorubicin—testicular cancer	0.000318	0.000392	CcSEcCtD
Vigabatrin—Dizziness—Epirubicin—testicular cancer	0.000317	0.000391	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—testicular cancer	0.000314	0.000387	CcSEcCtD
Vigabatrin—Vomiting—Epirubicin—testicular cancer	0.000305	0.000376	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—testicular cancer	0.000304	0.000375	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—testicular cancer	0.000304	0.000374	CcSEcCtD
Vigabatrin—Rash—Epirubicin—testicular cancer	0.000302	0.000373	CcSEcCtD
Vigabatrin—Dermatitis—Epirubicin—testicular cancer	0.000302	0.000372	CcSEcCtD
Vigabatrin—Headache—Epirubicin—testicular cancer	0.0003	0.00037	CcSEcCtD
Vigabatrin—Dizziness—Doxorubicin—testicular cancer	0.000293	0.000362	CcSEcCtD
Vigabatrin—Nausea—Epirubicin—testicular cancer	0.000285	0.000351	CcSEcCtD
Vigabatrin—Vomiting—Doxorubicin—testicular cancer	0.000282	0.000348	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—testicular cancer	0.00028	0.000345	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—testicular cancer	0.00028	0.000345	CcSEcCtD
Vigabatrin—Headache—Doxorubicin—testicular cancer	0.000278	0.000343	CcSEcCtD
Vigabatrin—Nausea—Doxorubicin—testicular cancer	0.000264	0.000325	CcSEcCtD
